桥本甲状腺炎中CD4+CD25-和CD4+CD25+ T细胞的不同n -糖基化谱

IF 5.9 2区 医学 Q1 IMMUNOLOGY
Frontiers in Immunology Pub Date : 2025-09-15 eCollection Date: 2025-01-01 DOI:10.3389/fimmu.2025.1633344
Sara Trzos, Marta Szewczyk, Paweł Link-Lenczowski, Grzegorz Sokołowski, Małgorzata Trofimiuk-Müldner, Katarzyna Bocian, Ewa Pocheć
{"title":"桥本甲状腺炎中CD4+CD25-和CD4+CD25+ T细胞的不同n -糖基化谱","authors":"Sara Trzos, Marta Szewczyk, Paweł Link-Lenczowski, Grzegorz Sokołowski, Małgorzata Trofimiuk-Müldner, Katarzyna Bocian, Ewa Pocheć","doi":"10.3389/fimmu.2025.1633344","DOIUrl":null,"url":null,"abstract":"<p><p>Hashimoto's thyroiditis (HT) is one of the most common organ-specific autoimmune diseases, characterized by chronic thyroid gland inflammation. Helper T (Th) CD4<sup>+</sup> cells, whose surface receptors are highly glycosylated, are involved in the pathomechanism of HT. Our study aimed to characterize <i>N</i>-glycosylation profiles in two pools of CD4<sup>+</sup> T cells, defined by the expression of CD25<sup>+</sup> late activation marker (CD4<sup>+</sup>CD25<sup>+</sup>) and CD25-negative cells (CD4<sup>+</sup>CD25<sup>-</sup>) in HT. Two study groups were recruited: HT1 with elevated thyroid autoantibodies and TSH level within the normal range without hypothyroidism, and HT2, hypothyroid HT patients, adequately metabolically controlled while on L-thyroxine replacement therapy, and healthy subjects to the control group (CTR). <i>N</i>-glycans from CD4<sup>+</sup> cell proteins, released using <i>N</i>-glycosidase F, were analyzed by MALDI-Tof mass spectrometry. RT-qPCR was used to determine the expression of selected glycogenes. We found significant differences in the glycome of CD4<sup>+</sup>CD25<sup>-</sup> and CD4<sup>+</sup>CD25<sup>+</sup> cells. In homeostasis (CTR), a predominance of complex-type glycans was observed in CD4<sup>+</sup>CD25<sup>-</sup> cells, whereas the oligomannose-type structures prevail in CD4<sup>+</sup>CD25<sup>+</sup> lymphocytes. In autoimmunity and progressive thyroid dysfunction, the rearrangement of <i>N</i>-glycans in Th cells was observed, in opposite directions in the CD4<sup>+</sup> pools. Complex-type structures are replaced by oligomannose forms in CD4<sup>+</sup>CD25<sup>-</sup> in the HT1 group, while in HT2, a restoration of glycosylation profile to the level of CTR was detected. CD4<sup>+</sup>CD25<sup>+</sup> cells accelerated complex-type synthesis in HT1, which was normalized in HT2 patients. Changes in the profile of <i>N</i>-linked glycans are partially reflected in the expression of mannosidases and glycosyltransferases. Our study demonstrates for the first time the diverse <i>N</i>-glycosylation profiles in CD4<sup>+</sup>CD25<sup>-</sup> and CD4<sup>+</sup>CD25<sup>+</sup> cells, and the rearrangement of <i>N</i>-glycan structures specific for each pool of Th cells in HT. Further studies are needed to determine the functional aspect of the identified <i>N</i>-glycosylation changes during thyroid autoimmunity.</p>","PeriodicalId":12622,"journal":{"name":"Frontiers in Immunology","volume":"16 ","pages":"1633344"},"PeriodicalIF":5.9000,"publicationDate":"2025-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477247/pdf/","citationCount":"0","resultStr":"{\"title\":\"The diverse <i>N</i>-glycosylation profiles of CD4<sup>+</sup>CD25<sup>-</sup> and CD4<sup>+</sup>CD25<sup>+</sup> T cells in Hashimoto's thyroiditis.\",\"authors\":\"Sara Trzos, Marta Szewczyk, Paweł Link-Lenczowski, Grzegorz Sokołowski, Małgorzata Trofimiuk-Müldner, Katarzyna Bocian, Ewa Pocheć\",\"doi\":\"10.3389/fimmu.2025.1633344\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hashimoto's thyroiditis (HT) is one of the most common organ-specific autoimmune diseases, characterized by chronic thyroid gland inflammation. Helper T (Th) CD4<sup>+</sup> cells, whose surface receptors are highly glycosylated, are involved in the pathomechanism of HT. Our study aimed to characterize <i>N</i>-glycosylation profiles in two pools of CD4<sup>+</sup> T cells, defined by the expression of CD25<sup>+</sup> late activation marker (CD4<sup>+</sup>CD25<sup>+</sup>) and CD25-negative cells (CD4<sup>+</sup>CD25<sup>-</sup>) in HT. Two study groups were recruited: HT1 with elevated thyroid autoantibodies and TSH level within the normal range without hypothyroidism, and HT2, hypothyroid HT patients, adequately metabolically controlled while on L-thyroxine replacement therapy, and healthy subjects to the control group (CTR). <i>N</i>-glycans from CD4<sup>+</sup> cell proteins, released using <i>N</i>-glycosidase F, were analyzed by MALDI-Tof mass spectrometry. RT-qPCR was used to determine the expression of selected glycogenes. We found significant differences in the glycome of CD4<sup>+</sup>CD25<sup>-</sup> and CD4<sup>+</sup>CD25<sup>+</sup> cells. In homeostasis (CTR), a predominance of complex-type glycans was observed in CD4<sup>+</sup>CD25<sup>-</sup> cells, whereas the oligomannose-type structures prevail in CD4<sup>+</sup>CD25<sup>+</sup> lymphocytes. In autoimmunity and progressive thyroid dysfunction, the rearrangement of <i>N</i>-glycans in Th cells was observed, in opposite directions in the CD4<sup>+</sup> pools. Complex-type structures are replaced by oligomannose forms in CD4<sup>+</sup>CD25<sup>-</sup> in the HT1 group, while in HT2, a restoration of glycosylation profile to the level of CTR was detected. CD4<sup>+</sup>CD25<sup>+</sup> cells accelerated complex-type synthesis in HT1, which was normalized in HT2 patients. Changes in the profile of <i>N</i>-linked glycans are partially reflected in the expression of mannosidases and glycosyltransferases. Our study demonstrates for the first time the diverse <i>N</i>-glycosylation profiles in CD4<sup>+</sup>CD25<sup>-</sup> and CD4<sup>+</sup>CD25<sup>+</sup> cells, and the rearrangement of <i>N</i>-glycan structures specific for each pool of Th cells in HT. Further studies are needed to determine the functional aspect of the identified <i>N</i>-glycosylation changes during thyroid autoimmunity.</p>\",\"PeriodicalId\":12622,\"journal\":{\"name\":\"Frontiers in Immunology\",\"volume\":\"16 \",\"pages\":\"1633344\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12477247/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fimmu.2025.1633344\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fimmu.2025.1633344","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

桥本甲状腺炎是最常见的器官特异性自身免疫性疾病之一,以慢性甲状腺炎症为特征。辅助性T (Th) CD4+细胞,其表面受体高度糖基化,参与了HT的病理机制。我们的研究旨在表征两种CD4+ T细胞池中的n -糖基化谱,这两种细胞池由CD25+晚期激活标记(CD4+CD25+)和CD25阴性细胞(CD4+CD25-)在HT中的表达定义。我们招募了两个研究组:HT1,甲状腺自身抗体和TSH水平在正常范围内升高,没有甲状腺功能减退;HT2,甲状腺功能减退HT患者,在l -甲状腺素替代治疗期间代谢得到充分控制,健康受试者为对照组(CTR)。利用n -糖苷酶F释放CD4+细胞蛋白中的n -聚糖,用MALDI-Tof质谱法分析。采用RT-qPCR检测所选糖基因的表达情况。我们发现CD4+CD25-和CD4+CD25+细胞的血糖有显著差异。在稳态(CTR)中,在CD4+CD25-细胞中观察到复合物型聚糖的优势,而在CD4+CD25+淋巴细胞中则以寡糖型结构为主。在自身免疫和进行性甲状腺功能障碍中,观察到Th细胞中n -聚糖的重排,在CD4+池中方向相反。在HT1组中,CD4+CD25-中的复合物型结构被低甘露糖形式所取代,而在HT2中,检测到糖基化谱恢复到CTR水平。CD4+CD25+细胞在HT1中加速复合物型合成,在HT2患者中呈正常化。n链聚糖谱的变化部分反映在甘露糖苷酶和糖基转移酶的表达上。我们的研究首次证明了CD4+CD25-和CD4+CD25+细胞中不同的n -糖基化谱,以及HT中每种Th细胞特异性n -糖基结构的重排。需要进一步的研究来确定甲状腺自身免疫过程中n -糖基化变化的功能方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The diverse N-glycosylation profiles of CD4+CD25- and CD4+CD25+ T cells in Hashimoto's thyroiditis.

Hashimoto's thyroiditis (HT) is one of the most common organ-specific autoimmune diseases, characterized by chronic thyroid gland inflammation. Helper T (Th) CD4+ cells, whose surface receptors are highly glycosylated, are involved in the pathomechanism of HT. Our study aimed to characterize N-glycosylation profiles in two pools of CD4+ T cells, defined by the expression of CD25+ late activation marker (CD4+CD25+) and CD25-negative cells (CD4+CD25-) in HT. Two study groups were recruited: HT1 with elevated thyroid autoantibodies and TSH level within the normal range without hypothyroidism, and HT2, hypothyroid HT patients, adequately metabolically controlled while on L-thyroxine replacement therapy, and healthy subjects to the control group (CTR). N-glycans from CD4+ cell proteins, released using N-glycosidase F, were analyzed by MALDI-Tof mass spectrometry. RT-qPCR was used to determine the expression of selected glycogenes. We found significant differences in the glycome of CD4+CD25- and CD4+CD25+ cells. In homeostasis (CTR), a predominance of complex-type glycans was observed in CD4+CD25- cells, whereas the oligomannose-type structures prevail in CD4+CD25+ lymphocytes. In autoimmunity and progressive thyroid dysfunction, the rearrangement of N-glycans in Th cells was observed, in opposite directions in the CD4+ pools. Complex-type structures are replaced by oligomannose forms in CD4+CD25- in the HT1 group, while in HT2, a restoration of glycosylation profile to the level of CTR was detected. CD4+CD25+ cells accelerated complex-type synthesis in HT1, which was normalized in HT2 patients. Changes in the profile of N-linked glycans are partially reflected in the expression of mannosidases and glycosyltransferases. Our study demonstrates for the first time the diverse N-glycosylation profiles in CD4+CD25- and CD4+CD25+ cells, and the rearrangement of N-glycan structures specific for each pool of Th cells in HT. Further studies are needed to determine the functional aspect of the identified N-glycosylation changes during thyroid autoimmunity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.80
自引率
11.00%
发文量
7153
审稿时长
14 weeks
期刊介绍: Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信